Related Experiment Videos

Simvastatin improved arterial compliance in high-risk patients

Gocha Saliashvili1, Warren W Davis, Matthey T Harris

  • 1Emory University School of Medicine, Decatur, GA 30033, USA.

Vascular and Endovascular Surgery
|December 14, 2004
PubMed

Insights

Statin therapy significantly improved arterial compliance in the thigh for patients with coronary artery disease or diabetes. This suggests smooth muscle tone influences arterial health and highlights a potential monitoring tool for high-risk individuals.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Vascular Biology

Background:

  • Reduced arterial compliance is a marker of arteriosclerosis.
  • Abnormal vascular tone, influenced by low-density lipoprotein (LDL) cholesterol, contributes to arterial stiffening.
  • Statin therapy is a common intervention for managing cholesterol levels.

Purpose of the Study:

  • To evaluate the efficacy of statin therapy in enhancing arterial compliance.
  • To assess the impact of simvastatin on arterial compliance in patients with coronary artery disease (CAD) and/or diabetes.

Main Methods:

  • A cohort of 10 patients with proven CAD received simvastatin (40 mg/day) for 4 months.
  • Arterial compliance was measured using air plethysmography at the thigh and calf.
  • Measurements were taken at baseline, 2 months, and 4 months.

Main Results:

  • Arterial compliance in the thigh demonstrated a significant improvement in all patients within 2 months.
  • Thigh arterial compliance increased by 34% by the end of the 4-month study period.
  • No significant changes in arterial compliance were observed at the calf.

Conclusions:

  • Statin therapy, specifically simvastatin, effectively improves arterial compliance in the thigh.
  • Findings suggest that smooth muscle tone plays a key role in regulating thigh arterial compliance.
  • Thigh and calf compliance measurements may serve as valuable indicators for assessing high-risk patients and monitoring cholesterol-lowering treatments.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...